Pharmaceutical Commerce - January/February 2010

Launch includes a delayed-release formulation, in-house and contract sales force, a REMS program and a patient-adherence program

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs; also objects to restrictions on wholesale-distribution

CRM vendor invests in data sources to upgrade its offerings for life sciences regulatory and marketing operations

Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps

Participants will meet quarterly throughout the year to create supply chain use-scenarios with GS1 standards

Updated survey finds some improvements, but little overall progress since a 2006 survey

In the past year, FDA has imposed REMS programs for one out of four new drug approvals